- Home
- PTHL vs STRW Comparison
PTHL vs STRW Comparison
Compare PTHL & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTHL | STRW |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 151.1M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTHL | STRW |
|---|---|---|
| Price | $0.49 | $13.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $12.72 |
| AVG Volume (30 Days) | ★ 94.5K | 34.0K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.78% |
| EPS Growth | N/A | ★ 19.41 |
| EPS | N/A | ★ 0.61 |
| Revenue | $305,215.00 | ★ $145,392,000.00 |
| Revenue This Year | N/A | $35.42 |
| Revenue Next Year | N/A | $7.19 |
| P/E Ratio | ★ N/A | $21.58 |
| Revenue Growth | N/A | ★ 29.76 |
| 52 Week Low | $0.47 | $8.70 |
| 52 Week High | $32.00 | $14.00 |
Technical Indicators
Market Signals| Indicator | PTHL | STRW |
|---|---|---|
| Relative Strength Index (RSI) | 30.70 | 59.46 |
| Support Level | $0.48 | $13.07 |
| Resistance Level | $0.55 | $14.00 |
| Average True Range (ATR) | 0.04 | 0.55 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 11.13 | 58.33 |
Price Performance
Historical ComparisonAbout PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.